| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048126986 |
| P356 | DOI | 10.1007/S12263-011-0209-Y |
| P932 | PMC publication ID | 3092902 |
| P698 | PubMed publication ID | 21484164 |
| P5875 | ResearchGate publication ID | 51042915 |
| P2093 | author name string | Kidong Kim | |
| Jae Yong Han | |||
| Jeong Mook Lim | |||
| Mi-Kyung Kim | |||
| Yong Sang Song | |||
| P2860 | cites work | Immunity, Inflammation, and Cancer | Q27861048 |
| Analgesic drug use and risk of ovarian cancer | Q28193965 | ||
| Celecoxib for the prevention of colorectal adenomatous polyps | Q28200375 | ||
| Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells | Q28283966 | ||
| Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids | Q28300710 | ||
| Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol | Q28343253 | ||
| Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells | Q28370037 | ||
| Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure | Q28377793 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Cancer chemoprevention with dietary phytochemicals | Q29617743 | ||
| Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
| Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation | Q31393490 | ||
| Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. | Q31413445 | ||
| Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. | Q33506168 | ||
| Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice | Q33671139 | ||
| Possible role of ovarian epithelial inflammation in ovarian cancer | Q33724007 | ||
| NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer | Q33979905 | ||
| Incessant ovulation--a factor in ovarian neoplasia? | Q34051579 | ||
| Epithelial ovarian cancer risk among women with polycystic ovary syndrome | Q34400660 | ||
| Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. | Q34552323 | ||
| Curcumin as "Curecumin": from kitchen to clinic. | Q34694680 | ||
| Phase II trial of curcumin in patients with advanced pancreatic cancer | Q34796370 | ||
| Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. | Q35864060 | ||
| Cyclooxygenases in cancer: chemoprevention and sensitization to conventional therapies | Q36536273 | ||
| Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. | Q36591918 | ||
| Inflammation and cancer: an ancient link with novel potentials. | Q36950961 | ||
| Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. | Q37032474 | ||
| Early events in the pathogenesis of epithelial ovarian cancer | Q37057044 | ||
| Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin | Q37089549 | ||
| Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins | Q37163664 | ||
| Perspectives for cancer prevention with natural compounds | Q37212228 | ||
| Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells | Q37255401 | ||
| Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin | Q37351855 | ||
| Multiple Anticancer Activities of EF24, a Novel Curcumin Analog, on Human Ovarian Carcinoma Cells | Q39669843 | ||
| Epigallocatechin-3-gallate, a natural polyphenol, inhibits cell proliferation and induces apoptosis in human ovarian cancer cells. | Q39671843 | ||
| Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways | Q39803277 | ||
| Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol | Q40071351 | ||
| Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. | Q40164519 | ||
| Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells | Q40172682 | ||
| Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. | Q40308148 | ||
| Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice | Q40358890 | ||
| Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated prot | Q40399280 | ||
| Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. | Q40478968 | ||
| Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines | Q40518865 | ||
| trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells | Q40527959 | ||
| Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways | Q40684457 | ||
| Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity | Q40930583 | ||
| Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target | Q42834044 | ||
| Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china | Q43852669 | ||
| Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis | Q44189582 | ||
| Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents | Q44226844 | ||
| Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells | Q44534508 | ||
| Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes | Q44776069 | ||
| Over-the-counter analgesics and risk of ovarian cancer | Q44960239 | ||
| Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance | Q45122000 | ||
| Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects | Q46850317 | ||
| Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer | Q48035577 | ||
| In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. | Q51568395 | ||
| Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. | Q53424898 | ||
| Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. | Q53625213 | ||
| Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis | Q58629377 | ||
| Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group | Q67979093 | ||
| Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] | Q71743409 | ||
| Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound | Q72388341 | ||
| Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex | Q73171123 | ||
| Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer | Q78109160 | ||
| Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets | Q79712726 | ||
| Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway | Q80421999 | ||
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| ovarian cancer | Q172341 | ||
| phytochemistry | Q640068 | ||
| P304 | page(s) | 109-115 | |
| P577 | publication date | 2011-02-04 | |
| P1433 | published in | Genes & Nutrition | Q19850987 |
| P1476 | title | Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer | |
| P478 | volume | 6 |
| Q38610764 | Anti-Inflammatory Effects of Curcumin on Insulin Resistance Index, Levels of Interleukin-6, C-Reactive Protein, and Liver Histology in Polycystic Ovary Syndrome-Induced Rats. |
| Q35821696 | Anti-Inflammatory Effects of Novel Standardized Solid Lipid Curcumin Formulations |
| Q38177316 | Antiangiogenic agents in natural products for the treatment of gynecologic disorders. |
| Q36017531 | BRCA1 185delAG Mutation Enhances Interleukin-1β Expression in Ovarian Surface Epithelial Cells |
| Q33891573 | Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer |
| Q37618157 | Genistein as a Potential Anticancer Agent against Ovarian Cancer. |
| Q98386077 | Phytoestrogen genistein hinders ovarian oxidative damage and apoptotic cell death-induced by ionizing radiation: co-operative role of ER-β, TGF-β, and FOXL-2 |
| Q38082941 | Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies. |
| Q95852125 | The Role of Secondary Metabolites on Gynecologic Cancer Therapy: Some Pathways and Mechanisms |
| Q43532370 | The potential chemoprotective effects of melatonin against genotoxicity induced by diazinon in human peripheral blood lymphocytes |
Search more.